Malassezia species in skin diseases

Current Opinion in Infectious Diseases

Volumn 15, Issue 2, 2002, Pages 133-142

  Crespo Erchiga, Vicente ^a   Delgado Florencio, Vicente ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATOPIC DERMATITIS; FOLLICULITIS; HUMAN; IMMUNOPATHOGENESIS; MALASSEZIA; ONYCHOMYCOSIS; OTITIS; PAPILLOMATOSIS; PUSTULOSIS; REVIEW; SEBORRHEIC DERMATITIS; SKIN INFECTION; SPECIES; TAXONOMY; YEAST;

EID: 0036213639     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200204000-00006     Document Type: Review

References (61)

1. Fungal structures in pityriasis versicolor
2. The genus Malassezia with description of four new species
3. Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis
4. Malassezia furfur
5. Diseases caused by Malassezia species
6. The role of Malassezia species in the ecology of human skin and as pathogens
7. Identification of Malassezia species. A practical approach
8. Molecular differentiation of seven Malassezia species
9. A single PCR-restriction endonuclease analysis for rapid identification of Malassezia species
10. Human infections due to Malassezia spp
11. Isolation and identification of Malassezia spp. in pityriasis versicolor, sebhorroeic dermatitis and healthy skin
12. E. Mycology of pityriasis versicolor
13. Differentiation of three biotypes of Malassezia species on normal human skin. Correspondence with M. globosa, M. sympodialis and M. restricta
14. The lipophilic yeasts: State of the art and prospects
15. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects
16. The yeast Malassezia on the skin of healthy individuals and patients with atopic dermatitis
17. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses
18. Lipophilic yeast organism associated with tinea versicolor
19. The lipophilic mycoflora of the skin. I. In vitro culture of Pityrosporum orbiculare n.sp
20. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada
21. Malassezia globosa as the causative agent of pityriasis versicolor
22. Humoral immunity in patients with tinea versicolor
23. Serological responses to Pityrosporum (Malassezia) in seborrrhoeic dermatitis demonstrated Dy ELISA and Western blotting
24. Antibodies to Pityrosporum orbiculare in patients with tinea versicolor and controls of various ages
25. Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls
26. Cell-mediated immunity to the mycelial phase of Malassezia spp. in patients with pityriasis versicolor and controls
27. The etiology of dandruff and the mode of action of therapeutic agents
28. Humoral immune response to Malassezia furfur in patients with pityriasis versicolor and seborrhoeic dermatitis
29. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeasts
30. Effects of Pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis anc cytokine (IL-2, IL-10, IFN-gamma) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis
31. Cell-mediated immune response to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls
32. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis. Characterization of inflammatory cells and mediators in the skin by immunohistochemistry
33. The effects of lipid extraction on the immunomodulatory activity of Malassezia species in vitro
34. Treatment of dermatitis of the head and neck with ketoconazole in patients with type I sensitivity to Pityrosporum orbiculare
35. Pityrosporum species as a cause of allergy and infection
36. Positive atopy patch test reactions to Pityrosporum orbiculare in atopic dermatitis patients
37. The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis
38. Isolation and characterization of a major antigenic component of Malassezia globosa to IgE antibodies in sera of patients with atopic dermatitis
39. Pityrosporum folliculitis: Renal transplantation case report
40. An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: A previously unrecognized nosocomial infection
41. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients
42. Pityrosporum folliculitis: A common disease of the young and middle aged
43. Confluent and reticulate papillomatosis (Gougerot-Carteaud) and Pityrosporum orbiculare
44. Confluent and reticulated papillomatosis responsive to selenium sulfide
45. Confluent and reticulated papillomatosis responsive to minocycline
46. Confluent and reticulated papillomatosis: Treatment with etretinate
47. Neonatal pustulosis caused by Malassezia furfur
48. Neonatal Malassezia furfur pustulosis
49. Neonatal Malassezia furfur pustulosis
50. Malignant otitis externa caused by Malassezia sympodialis
51. Malassezia pachydermatis; a review
52. Atypical lipid-dependent Malassezia species isolated from dogs with otitis externa
53. Otitis externa associated with Malassezia sympodialis in two cats
54. Onychomycosis due to Pityrosporum
55. Isolation of Malassezia furfur from patients with onychomycosis
56. Onychomycosis due to Malassezia
57. Antifungal in vitro susceptibility of Malassezia yeasts
58. In vitro activities of ketoconazole, econazole, miconazole and Melaleuca alternifolia (tea tree) oil against Malassezia species
59. Susceptibility testing of Malassezia species using the urea broth microdilution method
60. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine